1
|
Larici AR, Biederer J, Cicchetti G, Franquet Casas T, Screaton N, Remy-Jardin M, Parkar A, Prosch H, Schaefer-Prokop C, Frauenfelder T, Ghaye B, Sverzellati N. ESR Essentials: imaging in fibrotic lung diseases-practice recommendations by the European Society of Thoracic Imaging. Eur Radiol 2025; 35:2245-2255. [PMID: 39242399 PMCID: PMC11914337 DOI: 10.1007/s00330-024-11054-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/25/2024] [Revised: 07/29/2024] [Accepted: 08/03/2024] [Indexed: 09/09/2024]
Abstract
Fibrotic lung diseases (FLDs) represent a subgroup of interstitial lung diseases (ILDs), which can progress over time and carry a poor prognosis. Imaging has increased diagnostic discrimination in the evaluation of FLDs. International guidelines have stated the role of radiologists in the diagnosis and management of FLDs, in the context of the interdisciplinary discussion. Chest computed tomography (CT) with high-resolution technique is recommended to correctly recognise signs, patterns, and distribution of individual FLDs. Radiologists may be the first to recognise the presence of previously unknown interstitial lung abnormalities (ILAs) in various settings. A systematic approach to CT images may lead to a non-invasive diagnosis of FLDs. Careful comparison of serial CT exams is crucial in determining either disease progression or supervening complications. This 'Essentials' aims to provide radiologists a concise and practical approach to FLDs, focusing on CT technical requirements, pattern recognition, and assessment of disease progression and complications. Hot topics such as ILAs and progressive pulmonary fibrosis (PPF) are also discussed. KEY POINTS: Chest CT with high-resolution technique is the recommended imaging modality to diagnose pulmonary fibrosis. CT pattern recognition is central for an accurate diagnosis of fibrotic lung diseases (FLDs) by interdisciplinary discussion. Radiologists are to evaluate disease behaviour by accurately comparing serial CT scans.
Collapse
Affiliation(s)
- Anna Rita Larici
- Department of Radiological and Hematological Sciences, Catholic University of the Sacred Heart, Rome, Italy.
- Department of Diagnostic Imaging and Oncological Radiotherapy, Advanced Radiology Center, 'A. Gemelli' University Polyclinic Foundation IRCCS, Rome, Italy.
| | - Juergen Biederer
- Diagnostic and Interventional Radiology, University Hospital, Heidelberg, Germany
- Translational Lung Research Center Heidelberg (TLRC), Member of the German Center for Lung Research (DZL), Heidelberg, Germany
- University of Latvia, Faculty of Medicine, Riga, Latvia
- Christian-Albrechts-Universität zu Kiel, Faculty of Medicine, Kiel, Germany
| | - Giuseppe Cicchetti
- Department of Diagnostic Imaging and Oncological Radiotherapy, Advanced Radiology Center, 'A. Gemelli' University Polyclinic Foundation IRCCS, Rome, Italy
| | | | - Nick Screaton
- Department of Radiology, Royal Papworth Hospital NHSFT, Cambridge, United Kingdom
| | - Martine Remy-Jardin
- IMALLIANCE-Haut-de-France, Valenciennes, France
- Department of Thoracic Imaging, University of Lille, Lille, France
| | - Anagha Parkar
- Radiology Department, Haraldsplass Deaconess Hospital, Bergen, Norway
- Department of Clinical Medicine, Faculty of Medicine and Dentistry, University of Bergen, Bergen, Norway
| | - Helmut Prosch
- Department of Radiology, Medical University of Vienna, Vienna, Austria
| | - Cornelia Schaefer-Prokop
- Radiology, Meander Medical Centre Amersfoort, Amersfoort, Netherlands
- Department of Radiology, Nuclear Medicine and Anatomy, RadboudUMC, Nijmegen, Netherlands
| | - Thomas Frauenfelder
- Diagnostic and Interventional Radiology, University Hospital Zurich, University Zurich, Zurich, Switzerland
| | - Benoit Ghaye
- Department of Radiology, Cliniques Universitaires St-Luc, Catholic University of Louvain, Brussels, Belgium
| | - Nicola Sverzellati
- Scienze Radiologiche, Department of Medicine and Surgery, University of Parma, Parma, Italy
| |
Collapse
|
2
|
Elshetry ASF, Mahmoud El-Fawakry R, Zaiton F, Mohamed Alsowey A, Abdelfatah Frere R, El-Sayed Abdel Aziz E, Seleem Mahmoud N, Mohamed Roushdy Y, Mostafa Hassan R. Clinical utility, reproducibility, and radiologist acceptance of ILD-RADS. Eur J Radiol 2024; 175:111473. [PMID: 38643528 DOI: 10.1016/j.ejrad.2024.111473] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2023] [Revised: 03/28/2024] [Accepted: 04/15/2024] [Indexed: 04/23/2024]
Abstract
PURPOSE To investigate the clinical utility, reproducibility, and radiologists' acceptance of the Interstitial Lung Disease Imaging-Reporting and Data System (ILD-RADS). METHOD In this single-institutional retrospective study, three radiologists independently reviewed the chest high-resolution CT (HRCT) scans of 111 consecutive patients diagnosed with ILDs. They assessed the HRCT pulmonary features using the ILD-RADS template and assigned an ILD-RADS category (1-4) to each scan based on the identified imaging pattern. Patients were classified into idiopathic pulmonary fibrosis (IPF) (n = 14) and non-IPF ILD (n = 97) groups based on clinical diagnoses determined by multidisciplinary discussion. Association between ILD-RADS categories and clinical diagnoses was assessed using the Chi-square test for trend. Reproducibility was evaluated using kappa (k) scores, and radiologists' acceptance of the ILD-RADS was evaluated with a questionnaire. RESULTS We found a significant association between the ILD-RADS categories and patients' clinical diagnoses (P ≤ 0.0001) for the three readers, with a trend toward increased assignment of ILD-RADS-1 to IPF patients (50 %-57.1 %), and ILD-RADS-4 to non-IPF patients (46.4 %-49.5 %). The ILD-RADS categories showed excellent intra-reader agreement (k = 0.873) and moderate inter-reader agreement (k = 0.440). ILD-RADS-1 and -4 categories showed the highest inter-reader agreement (k = 0.681 and 0.481, respectively). Radiologists gave a positive response to using the ILD-RADS in daily practice. CONCLUSIONS The clinical utility of the ILD-RADS was demonstrated by the significant association between the ILD-RADS categories and patients' clinical diagnoses, particularly the ILD-RADS-1 and -4 categories. Excellent intra-reader and moderate inter-reader reproducibility was observed. ILD-RADS has the potential to be widely accepted for standardized HRCT reporting among radiologists.
Collapse
Affiliation(s)
| | | | - Fatma Zaiton
- Radio-diagnosis department, Faculty of Human Medicine, Zagazig University, Zagazig, Egypt
| | - Ahmed Mohamed Alsowey
- Radio-diagnosis department, Faculty of Human Medicine, Zagazig University, Zagazig, Egypt
| | - Reem Abdelfatah Frere
- Radio-diagnosis department, Faculty of Human Medicine, Zagazig University, Zagazig, Egypt
| | | | | | | | - Rania Mostafa Hassan
- Radio-diagnosis department, Faculty of Human Medicine, Zagazig University, Zagazig, Egypt
| |
Collapse
|
3
|
Suman G, Koo CW. Recent Advancements in Computed Tomography Assessment of Fibrotic Interstitial Lung Diseases. J Thorac Imaging 2023; 38:S7-S18. [PMID: 37015833 DOI: 10.1097/rti.0000000000000705] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/06/2023]
Abstract
Interstitial lung disease (ILD) is a heterogeneous group of disorders with complex and varied imaging manifestations and prognosis. High-resolution computed tomography (HRCT) is the current standard-of-care imaging tool for ILD assessment. However, visual evaluation of HRCT is limited by interobserver variation and poor sensitivity for subtle changes. Such challenges have led to tremendous recent research interest in objective and reproducible methods to examine ILDs. Computer-aided CT analysis to include texture analysis and machine learning methods have recently been shown to be viable supplements to traditional visual assessment through improved characterization and quantification of ILDs. These quantitative tools have not only been shown to correlate well with pulmonary function tests and patient outcomes but are also useful in disease diagnosis, surveillance and management. In this review, we provide an overview of recent computer-aided tools in diagnosis, prognosis, and longitudinal evaluation of fibrotic ILDs, while outlining some of the pitfalls and challenges that have precluded further advancement of these tools as well as potential solutions and further endeavors.
Collapse
Affiliation(s)
- Garima Suman
- Division of Thoracic Imaging, Mayo Clinic, Rochester, MN
| | | |
Collapse
|
4
|
Hamer OW, Biederer J, Das M, Kauczor HU, Wielpütz MO, Ley-Zaporozhan J, Vogel-Claussen J, Wormanns D, Ley S. [Comment on: Notification of revised diagnostic reference levels for diagnostic and interventional X-Ray Procedures by the Bundesamt für Strahlenschutz]. ROFO-FORTSCHR RONTG 2022; 194:717-719. [PMID: 35817033 DOI: 10.1055/a-1813-3116] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Affiliation(s)
- Okka Wilkea Hamer
- Department of Radiology, University Medical Center Regensburg und Department of Radiology Lungenfachklinik Donaustauf
| | | | - Marco Das
- Department of Radiology, Helios Hospital Duisburg
| | | | | | | | | | - Dag Wormanns
- Department of Radiology, Evangelische Lungenklinik Berlin
| | - Sebastian Ley
- Department of Radiology, Chirurgisches Klinikum München-Süd
| |
Collapse
|
5
|
Henning MK, Aaløkken TM, Johansen S. Contrast medium protocols in routine chest CT: a survey study. Acta Radiol 2022; 63:351-359. [PMID: 33648351 DOI: 10.1177/0284185121997111] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
BACKGROUND Administration of contrast medium (CM) is an important image quality factor in computed tomography (CT) of the chest. There is no clear evidence or guidelines on CM strategies for chest CT, thus a consensus approach is needed. PURPOSE To survey the potential impact on differences in chest CT protocols, with emphasis on strategies for the administration of CM. MATERIAL AND METHODS A total of 170 respondents were included in this survey, which used two different approaches: (i) an online survey was sent to the members of the European Society of Thoracic Imaging (ESTI); and (ii) an email requesting a copy of their CT protocol was sent to all hospitals in Norway, and university hospitals in Sweden and Denmark. The survey focused on factors affecting CM protocols and enhancement in chest CT. RESULTS The overall response rate was 24% (n = 170): 76% of the respondents used a CM concentration of ≥350 mgI/mL; 52% of the respondents used a fixed CM volume strategy. Fixed strategies for injection rate and delay were also the most common approach, practiced by 73% and 57% of the respondents, respectively. The fixed delay was in the range of 20-90 s. Of the respondents, 56% used flexible tube potential strategies (kV). CONCLUSION The chest CT protocols and CM administration strategies employed by the respondents vary widely, affecting the image quality. The results of this study underline the need for further research and consensus guidelines related to chest CT.
Collapse
Affiliation(s)
- Mette Karen Henning
- Faculty of Health Sciences, Department of Life Sciences and Health, Oslo Metropolitan University, Oslo, Norway
- Department of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway
| | - Trond Mogens Aaløkken
- Department of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway
- Faulty of Medicine, University of Oslo, Oslo, Norway
| | - Safora Johansen
- Faculty of Health Sciences, Department of Life Sciences and Health, Oslo Metropolitan University, Oslo, Norway
- Department of Cancer Treatment, Oslo University Hospital, Oslo, Norway
| |
Collapse
|
6
|
Hobbs SB, Chung JH, Walker CM, Bang TJ, Carter BW, Christensen JD, Danoff SK, Kandathil A, Madan R, Moore WH, Shah SD, Kanne JP. ACR Appropriateness Criteria® Diffuse Lung Disease. J Am Coll Radiol 2021; 18:S320-S329. [PMID: 34794591 DOI: 10.1016/j.jacr.2021.08.008] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2021] [Accepted: 08/26/2021] [Indexed: 11/28/2022]
Abstract
Diffuse lung disease, frequently referred to as interstitial lung disease, encompasses numerous disorders affecting the lung parenchyma. The potential etiologies of diffuse lung disease are broad with several hundred established clinical syndromes and pathologies currently identified. Imaging plays a critical role in diagnosis and follow-up of many of these diseases, although multidisciplinary discussion is the current standard for diagnosis of several DLDs. This document aims to establish guidelines for evaluation of diffuse lung diseases for 1) initial imaging of suspected diffuse lung disease, 2) initial imaging of suspected acute exacerbation or acute deterioration in cases of confirmed diffuse lung disease, and 3) clinically indicated routine follow-up of confirmed diffuse lung disease without acute deterioration. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.
Collapse
Affiliation(s)
- Stephen B Hobbs
- Vice-Chair, Informatics and Integrated Clinical Operations and Division Chief, Cardiovascular and Thoracic Radiology, University of Kentucky, Lexington, Kentucky.
| | - Jonathan H Chung
- Panel Chair; and Vice-Chair of Quality, and Section Chief, Chest Imaging, Department of Radiology, University of Chicago, Chicago, Illinois
| | | | - Tami J Bang
- Co-Director, Cardiothoracic Imaging Fellowship Committee, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, Colorado; Co-Chair, membership committee, NASCI; and Membership committee, ad-hoc online content committee, STR
| | - Brett W Carter
- The University of Texas MD Anderson Cancer Center, Houston, Texas
| | - Jared D Christensen
- Vice-Chair, Department of Radiology, Duke University Medical Center, Durham, North Carolina; and Chair, ACR Lungs-RADS
| | - Sonye K Danoff
- Johns Hopkins Medicine, Baltimore, Maryland; Board of Directors, American Thoracic Society; Senior Medical Advisor, Pulmonary Fibrosis Foundation; and Medical Advisory Board Member, The Myositis Association
| | | | - Rachna Madan
- Associate Fellowship Director, Division of Thoracic Imaging, Brigham & Women's Hospital, Boston, Massachusetts
| | - William H Moore
- Associate Chair, Clinical Informatics and Chief, Thoracic Imaging, New York University Langone Medical Center, New York, New York
| | - Sachin D Shah
- Associate Chief and Medical Information Officer, University of Chicago, Chicago, Illinois; and Primary care physician
| | - Jeffrey P Kanne
- Specialty Chair, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin
| |
Collapse
|
7
|
|
8
|
Orlandi M, Landini N, Sambataro G, Nardi C, Tofani L, Bruni C, Bellando-Randone S, Blagojevic J, Melchiorre D, Hughes M, Denton CP, Luppi F, Ruaro B, Della Casa F, Rossi FW, De Luca G, Campochiaro C, Spinicci M, Zammarchi L, Tomassetti S, Caminati A, Cavigli E, Albanesi M, Melchiorre F, Palmucci S, Vegni V, Guiducci S, Moggi-Pignone A, Allanore Y, Bartoloni A, Confalonieri M, Dagna L, De Cobelli F, De Paulis A, Harari S, Khanna D, Kuwana M, Taliani G, Lavorini F, Miele V, Morana G, Pesci A, Vancheri C, Colagrande S, Matucci-Cerinic M. THE ROLE OF CHEST CT IN DECIPHERING INTERSTITIAL LUNG INVOLVEMENT: SYSTEMIC SCLEROSIS VERSUS COVID-19. Rheumatology (Oxford) 2021; 61:1600-1609. [PMID: 34320649 DOI: 10.1093/rheumatology/keab615] [Citation(s) in RCA: 51] [Impact Index Per Article: 12.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2021] [Revised: 07/09/2021] [Indexed: 11/14/2022] Open
Abstract
OBJECTIVE To identify the main computed tomography (CT) features that may help distinguishing a progression of interstitial lung disease (ILD) secondary to Systemic sclerosis (SSc) from COVID-19 pneumonia. METHODS This multicentric study included 22 international readers divided in the radiologist group (RAD) and non-radiologist group (nRAD). A total of 99 patients, 52 with COVID-19 and 47 with SSc-ILD, were included in the study. RESULTS Fibrosis inside focal ground glass opacities (GGO) in the upper lobes; fibrosis in the lower lobe GGO; reticulations in lower lobes (especially if bilateral and symmetrical or associated with signs of fibrosis) were the CT features most frequently associated with SSc-ILD. The CT features most frequently associated with COVID- 19 pneumonia were: consolidation (CONS) in the lower lobes, CONS with peripheral (both central/peripheral or patchy distributions), anterior and posterior CONS and rounded-shaped GGOs in the lower lobes. After multivariate analysis, the presence of CONS in the lower lobes (p < 0.0001) and signs of fibrosis in GGO in the lower lobes (p < 0.0001) remained independently associated with COVID-19 pneumonia or SSc-ILD, respectively. A predictive score was created which resulted positively associated with the COVID-19 diagnosis (96.1% sensitivity and 83.3% specificity). CONCLUSION The CT differential diagnosis between COVID-19 pneumonia and SSc-ILD is possible through the combination the proposed score and the radiologic expertise. The presence of consolidation in the lower lobes may suggest a COVID-19 pneumonia while the presence of fibrosis inside GGO may indicate a SSc-ILD.
Collapse
Affiliation(s)
- Martina Orlandi
- Department of Clinical and Experimental Medicine, University of Florence, University of Florence, Division of Rheumatology AOUC, Florence, Italy
| | - Nicholas Landini
- Department of Experimental and Clinical Biomedical Sciences, Radiodiagnostic Unit n. 2, University of Florence - AOUC, Largo Brambilla 3, 50134, Florence, Italy.,Department of Radiology, Ca' Foncello General Hospital, Piazzale Ospedale, 1, 31100, Treviso, Italy
| | - Gianluca Sambataro
- Regional Referral Centre for Rare Lung Diseases, A. O. U. "Policlinico G. Rodolico - San Marco" Dept. ofClinical and Experimental Medicine, University of Catania, Catania, Italy.,Artroreuma S.R.L., Rheumatology Outpatient Clinic Associated with the National Health System, Mascalucia(Catania), Italy
| | - Cosimo Nardi
- Department of Experimental and Clinical Biomedical Sciences, Radiodiagnostic Unit n. 2, University of Florence - AOUC, Largo Brambilla 3, 50134, Florence, Italy
| | - Lorenzo Tofani
- Department of Clinical and Experimental Medicine, University of Florence, University of Florence, Division of Rheumatology AOUC, Florence, Italy
| | - Cosimo Bruni
- Department of Clinical and Experimental Medicine, University of Florence, University of Florence, Division of Rheumatology AOUC, Florence, Italy
| | - Silvia Bellando-Randone
- Department of Clinical and Experimental Medicine, University of Florence, University of Florence, Division of Rheumatology AOUC, Florence, Italy
| | - Jelena Blagojevic
- Department of Clinical and Experimental Medicine, University of Florence, University of Florence, Division of Rheumatology AOUC, Florence, Italy
| | - Daniela Melchiorre
- Department of Clinical and Experimental Medicine, University of Florence, University of Florence, Division of Rheumatology AOUC, Florence, Italy
| | - Michael Hughes
- Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom
| | | | - Fabrizio Luppi
- Respiratory Unit, University of Milano-Bicocca, S. Gerardo Hospital, Monza, Italy
| | - Barbara Ruaro
- Department of Pulmonology, University Hospital of Cattinara, Trieste, Italy
| | - Francesca Della Casa
- Division of Autoimmune & Allergic Diseases, Department of Translational Medical Sciences. University ofNaples Federico II, Napoli, Italy
| | - Francesca W Rossi
- Division of Autoimmune & Allergic Diseases, Department of Translational Medical Sciences. University ofNaples Federico II, Napoli, Italy
| | - Giacomo De Luca
- Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Scientific Institute, VitaSalute San Raffaele University, Milan, Italy
| | - Corrado Campochiaro
- Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Scientific Institute, VitaSalute San Raffaele University, Milan, Italy
| | - Michele Spinicci
- Department of Experimental and Clinical Medicine, University of Florence, and Infectious and TropicalDiseases Unit, AOUC, Florence, Italy
| | - Lorenzo Zammarchi
- Department of Experimental and Clinical Medicine, University of Florence, and Infectious and TropicalDiseases Unit, AOUC, Florence, Italy
| | - Sara Tomassetti
- Department of Clinical and Experimental Medicine, University of Florence, Florence, Italy
| | | | - Edoardo Cavigli
- SOD Radiodiagnostica Emergenza-Urgenza, AOU Careggi, Florence, Italy
| | - Marco Albanesi
- SOD Radiodiagnostica Emergenza-Urgenza, AOU Careggi, Florence, Italy
| | - Fabio Melchiorre
- Department of Radiology Sant'Andrea Hospital Vercelli, ASLVC Italy
| | - Stefano Palmucci
- Radiodiagnostic and Radiotherapy Unit, Department of Medical Surgical Sciences and Advanced Technologies"GF Ingrassia", University of Catania, Italy
| | | | - Serena Guiducci
- Department of Clinical and Experimental Medicine, University of Florence, University of Florence, Division of Rheumatology AOUC, Florence, Italy
| | - Alberto Moggi-Pignone
- Department of Experimental and Clinical Medicine, AOU Careggi Hospital, University of Florence MedicalSchool, Florence, Italy
| | - Yannick Allanore
- Department of Rheumatology A, Descartes University, APHP, Cochin Hospital, Paris, France
| | - Alessandro Bartoloni
- Department of Experimental and Clinical Medicine, University of Florence, and Infectious and TropicalDiseases Unit, AOUC, Florence, Italy
| | - Marco Confalonieri
- Department of Pulmonology, University Hospital of Cattinara, Trieste, Italy
| | - Lorenzo Dagna
- Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Scientific Institute, VitaSalute San Raffaele University, Milan, Italy
| | - Francesco De Cobelli
- Department of Radiology IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan,Italy
| | - Amato De Paulis
- Division of Autoimmune & Allergic Diseases, Department of Translational Medical Sciences. University ofNaples Federico II, Napoli, Italy
| | - Sergio Harari
- U.O. di Pneumologia, Ospedale San Giuseppe MultiMedica, IRCCS.,Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Italy
| | - Dinesh Khanna
- Department of Medicine, University of Michigan, Ann Arbor, MI, USA
| | - Masataka Kuwana
- Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Tokyo, Japan
| | - Gloria Taliani
- Department of Translational and Precision Medicine, Sapienza University, Rome, Italy
| | - Federico Lavorini
- Department of Clinical and Experimental Medicine, University of Florence, Florence, Italy
| | - Vittorio Miele
- SOD Radiodiagnostica Emergenza-Urgenza, AOU Careggi, Florence, Italy
| | - Giovanni Morana
- Department of Radiology, Ca' Foncello General Hospital, Piazzale Ospedale, 1, 31100, Treviso, Italy
| | - Alberto Pesci
- Respiratory Unit, University of Milano-Bicocca, S. Gerardo Hospital, Monza, Italy
| | - Carlo Vancheri
- Regional Referral Centre for Rare Lung Diseases, A. O. U. "Policlinico G. Rodolico - San Marco" Dept. ofClinical and Experimental Medicine, University of Catania, Catania, Italy
| | - Stefano Colagrande
- Department of Experimental and Clinical Biomedical Sciences, Radiodiagnostic Unit n. 2, University of Florence - AOUC, Largo Brambilla 3, 50134, Florence, Italy
| | - Marco Matucci-Cerinic
- Department of Clinical and Experimental Medicine, University of Florence, University of Florence, Division of Rheumatology AOUC, Florence, Italy.,Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Scientific Institute, VitaSalute San Raffaele University, Milan, Italy
| |
Collapse
|
9
|
Booz C, Vogl TJ, Joseph Schoepf U, Caruso D, Inserra MC, Yel I, Martin SS, Bucher AM, Lenga L, Caudo D, Schreckenbach T, Schoell N, Huegel C, Stratmann J, Vasa-Nicotera M, Rachovitsky-Duarte DE, Laghi A, De Santis D, Mazziotti S, D'Angelo T, Albrecht MH. Value of minimum intensity projections for chest CT in COVID-19 patients. Eur J Radiol 2021; 135:109478. [PMID: 33360269 PMCID: PMC7831963 DOI: 10.1016/j.ejrad.2020.109478] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2020] [Accepted: 12/10/2020] [Indexed: 12/23/2022]
Abstract
PURPOSE To investigate whether minimum intensity projection (MinIP) reconstructions enable more accurate depiction of pulmonary ground-glass opacity (GGO) compared to standard transverse sections and multiplanar reformat (MPR) series in patients with suspected coronavirus disease 2019 (COVID-19). METHOD In this multinational study, chest CT scans of 185 patients were retrospectively analyzed. Diagnostic accuracy, diagnostic confidence, image quality regarding the assessment of GGO, as well as subjective time-efficiency of MinIP and standard MPR series were analyzed based on the assessment of six radiologists. In addition, the suitability for COVID-19 evaluation, image quality regarding GGO and subjective time-efficiency in clinical routine was assessed by five clinicians. RESULTS The reference standard revealed a total of 149 CT scans with pulmonary GGO. MinIP reconstructions yielded significantly higher sensitivity (99.9 % vs 95.6 %), specificity (95.8 % vs 86.1 %) and accuracy (99.1 % vs 93.8 %) for assessing of GGO compared with standard MPR series. MinIP reconstructions achieved significantly higher ratings by radiologists concerning diagnostic confidence (medians, 5.00 vs 4.00), image quality (medians, 4.00 vs 4.00), contrast between GGO and unaffected lung parenchyma (medians, 5.00 vs 4.00) as well as subjective time-efficiency (medians, 5.00 vs 4.00) compared with MPR-series (all P < .001). Clinicians preferred MinIP reconstructions for COVID-19 assessment (medians, 5.00 vs 3.00), image quality regarding GGO (medians, 5.00 vs 3.00) and subjective time-efficiency in clinical routine (medians, 5.00 vs 3.00). CONCLUSIONS MinIP reconstructions improve the assessment of COVID-19 in chest CT compared to standard images and may be suitable for routine application.
Collapse
Affiliation(s)
- Christian Booz
- Division of Experimental Imaging, Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt am Main, Germany
| | - Thomas J Vogl
- Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt am Main, Germany
| | - U Joseph Schoepf
- Department of Radiology and Radiological Science, Medical University of South Carolina, Charleston, USA
| | - Damiano Caruso
- Department of Radiology and Radiological Science, Medical University of South Carolina, Charleston, USA; Department of Radiological Sciences, Oncology and Pathology, Sapienzia University of Rome, Rome, Italy
| | | | - Ibrahim Yel
- Division of Experimental Imaging, Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt am Main, Germany
| | - Simon S Martin
- Division of Experimental Imaging, Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt am Main, Germany; Department of Radiology and Radiological Science, Medical University of South Carolina, Charleston, USA
| | - Andreas M Bucher
- Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt am Main, Germany; Department of Radiology and Radiological Science, Medical University of South Carolina, Charleston, USA
| | - Lukas Lenga
- Division of Experimental Imaging, Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt am Main, Germany
| | - Danilo Caudo
- Division of Experimental Imaging, Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt am Main, Germany; Department of Biomedical Sciences and Morphological and Functional Imaging, University of Messina, Messina, Italy
| | - Teresa Schreckenbach
- Department of General and Visceral Surgery, University Hospital Frankfurt, Frankfurt am Main, Germany
| | - Niklas Schoell
- Department of Pneumonology, University Hospital Frankfurt, Frankfurt am Main, Germany
| | - Christian Huegel
- Department of Pneumonology, University Hospital Frankfurt, Frankfurt am Main, Germany
| | - Jan Stratmann
- Department of Hematology and Oncology, University Hospital Frankfurt, Frankfurt am Main, Germany
| | | | | | - Andrea Laghi
- Department of Radiological Sciences, Oncology and Pathology, Sapienzia University of Rome, Rome, Italy
| | - Domenico De Santis
- Department of Radiology and Radiological Science, Medical University of South Carolina, Charleston, USA; Department of Radiological Sciences, Oncology and Pathology, Sapienzia University of Rome, Rome, Italy
| | - Silvio Mazziotti
- Department of Biomedical Sciences and Morphological and Functional Imaging, University of Messina, Messina, Italy
| | - Tommaso D'Angelo
- Department of Biomedical Sciences and Morphological and Functional Imaging, University of Messina, Messina, Italy; Department of Radiology, University Hospital Vittorio Emanuele Catania, Catania, Italy
| | - Moritz H Albrecht
- Division of Experimental Imaging, Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt am Main, Germany; Department of Radiology and Radiological Science, Medical University of South Carolina, Charleston, USA.
| |
Collapse
|
10
|
Interobserver variability in high-resolution CT of the lungs. Eur J Radiol Open 2020; 7:100228. [PMID: 32258248 PMCID: PMC7115039 DOI: 10.1016/j.ejro.2020.100228] [Citation(s) in RCA: 36] [Impact Index Per Article: 7.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2020] [Accepted: 03/05/2020] [Indexed: 11/21/2022] Open
Abstract
Purpose To quantify the interobserver variability among the most frequently encountered parenchymal patterns in High Resolution CT (HRCT) and to compare the interobserver variability in the application of the 2011 and 2018 usual interstitial pneumonia (UIP) criteria according to the joint guidelines from international thoracic and respiratory societies. Material and methods Two observers independently evaluated 126 HRCT, with examples of most common parenchymal patterns, and noted the presence of each pattern. The readers also noted whether the findings met the 2011 criteria for UIP. In a second reading, the same readers noted whether the HRCT met the UIP criteria according to the 2018 UIP update. Results The kappa values for interobserver variability for the different patterns ranged from 0.28 (intralobular lines) to 0.85 (tree-in-bud nodules). The kappa value for UIP pattern was similar for 2011 and 2018 criteria, 0.58 and 0.69, respectively. Compared to the 2011 UIP criteria, there was no statistically significant difference in the number of HRCT classified as UIP using the 2018 criteria. Conclusions There is a substantial variation in interobserver agreement between the different parenchymal patterns, which suggests that some patterns a more easily identified than others. There is also a considerable reader variation in the assessment of UIP applying the 2011 UIP criteria as well as applying the 2018 UIP update.
Collapse
|
11
|
Romei C, Turturici L, Tavanti L, Miedema J, Fiorini S, Marletta M, Wielopolski P, Tiddens H, Falaschi F, Ciet P. The use of chest magnetic resonance imaging in interstitial lung disease: a systematic review. Eur Respir Rev 2018; 27:27/150/180062. [PMID: 30567932 DOI: 10.1183/16000617.0062-2018] [Citation(s) in RCA: 31] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2018] [Accepted: 10/23/2018] [Indexed: 01/09/2023] Open
Abstract
Thin-slices multi-detector computed tomography (MDCT) plays a key role in the differential diagnosis of interstitial lung disease (ILD). However, thin-slices MDCT has a limited ability to detect active inflammation, which is an important target of newly developed ILD drug therapy. Magnetic resonance imaging (MRI), thanks to its multi-parameter capability, provides better tissue characterisation than thin-slices MDCT.Our aim was to summarise the current status of MRI applications in ILD and to propose an ILD-MRI protocol. A systematic literature search was conducted for relevant studies on chest MRI in patients with ILD.We retrieved 1246 papers of which 55 original papers were selected for the review. We identified 24 studies comparing image quality of thin-slices MDCT and MRI using several MRI sequences. These studies described new MRI sequences to assess ILD parenchymal abnormalities, such as honeycombing, reticulation and ground-glass opacity. Thin-slices MDCT remains superior to MRI for morphological imaging. However, recent studies with ultra-short echo-time MRI showed image quality comparable to thin-slices MDCT. Several studies demonstrated the added value of chest MRI by using functional imaging, especially to detect and quantify inflammatory changes.We concluded that chest MRI could play a role in ILD patients to differentiate inflammatory and fibrotic changes and to assess efficacy of new ILD drugs.
Collapse
Affiliation(s)
- Chiara Romei
- 2nd Radiology Unit, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy
| | - Laura Turturici
- Radiology, Azienda USL Toscana nord ovest Sede di Viareggio, Viareggio, Italy
| | - Laura Tavanti
- Dept of Surgical, Medical, Molecular Pathology and Critical Care, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy
| | - Jelle Miedema
- Dept of Respiratory Medicine, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands
| | - Sara Fiorini
- 1st Radiology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy
| | - Massimo Marletta
- 1st Radiology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy
| | - Piotr Wielopolski
- Dept of Radiology and Nuclear Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
| | - Harm Tiddens
- Dept of Radiology and Nuclear Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.,Dept of Pediatric Pulmonology and Allergology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
| | - Fabio Falaschi
- 2nd Radiology Unit, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy
| | - Pierluigi Ciet
- Dept of Radiology and Nuclear Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.,Dept of Pediatric Pulmonology and Allergology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
| |
Collapse
|
12
|
Increased Expiratory Computed Tomography Density Reveals Possible Abnormalities in Radiologically Preserved Lung Parenchyma in Idiopathic Pulmonary Fibrosis. Invest Radiol 2018; 53:45-51. [PMID: 28817393 DOI: 10.1097/rli.0000000000000405] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
OBJECTIVES Idiopathic pulmonary fibrosis (IPF) is a progressive lethal chronic lung disease with unclear pathogenesis. Radiological hallmark is the pattern of usual interstitial pneumonia accentuated in peripheral and basal areas with otherwise preserved lung structure. One hypothesis is that alveolar collapse and consequent induration lead to fibrotic transformation of lung tissue. The aim of the study was to investigate normal-appearing tissue during expiration for signs of collapsibility and differences from other diseases or controls. MATERIALS AND METHODS We retrospectively assessed a total of 43 patients (15 IPFs, 13 chronic obstructive pulmonary diseases, and 15 controls) with nonenhanced computed tomography (CT) in inspiration and expiration, performed for routine clinical workup. Densitometry of visually unaffected lung tissue was conducted in all lung lobes with a region of interest of 15-mm in diameter on soft tissue kernel reconstruction (slice thickness, 1 mm) during inspiration and expiration. RESULTS One-factor analysis of variance analysis yielded significant difference in attenuation changes between inspiration and expiration of unaffected lung parenchyma among all subject groups in all lung lobes. For IPF patients, the highest differences in densities were observed in the lower lobes, which is the predominantly affected site of usual interstitial pneumonia. In the chronic obstructive pulmonary disease group, the density remained rather equal in the entire lung. CONCLUSIONS High CT attenuation changes between inspiration and expiration in IPF patients might suggest altered lung parenchyma in normal-appearing tissue on CT. Density changes during the respiratory cycle might be explained by alveolar collapse of radiologically unaffected lung tissue possibly preceding fibrosis. These results support the concept of alveolar collapse preceding lung fibrosis in IPF.
Collapse
|
13
|
Abstract
The term interstitial lung diseases (ILD) comprises a diverse group of diseases that lead to inflammation and fibrosis of the alveoli, distal airways, and septal interstitium of the lungs. The ILD consist of disorders of known cause (e.g., collagen vascular diseases, drug-related diseases) as well as disorders of unknown etiology. The latter include idiopathic interstitial pneumonias (IIPs), and a group of miscellaneous, rare, but nonetheless interesting, diseases. In patients with ILD, MDCT enriches the diagnostic armamentarium by allowing volumetric high-resolution scanning, i.e., continuous data acquisition with thin collimation and a high spatial frequency reconstruction algorithm. CT is a key method in the identification and management of patients with ILD. It not only improves the detection and characterization of parenchymal abnormalities, but also increases the accuracy of diagnosis. The spectrum of morphologic characteristics that are indicative of interstitial lung disease is relatively limited and includes the linear and reticular pattern, the nodular pattern, the increased attenuation pattern (such as ground-glass opacities and consolidation), and the low attenuation pattern (such as emphysema and cystic lung diseases). In the correct clinical context, some patterns or combination of patterns, together with the anatomic distribution of the abnormality, i.e., from the lung apex to the base, or peripheral subpleural versus central bronchovascular, can lead the interpreter to a specific diagnosis. However, due to an overlap of the CT morphology between the various entities, the final diagnosis of many ILD requires close cooperation between clinicians and radiologists and complementary lung biopsy is recommended in many cases.
Collapse
Affiliation(s)
- Konstantin Nikolaou
- Department of Radiology, University Hospitals Tübingen, Tübingen, Baden-Württemberg Germany
| | - Fabian Bamberg
- Department of Diagnostic and Interventional Radiology, University of Freiburg, Freiburg, Germany
| | - Andrea Laghi
- Department of Surgical and Medical Sciences and Translational Medicine, “Sapienza” – University of Rome, Rome, Italy
| | - Geoffrey D. Rubin
- Department of Radiology, Duke University School of Medicine, Durham, NC USA
| |
Collapse
|
14
|
Sergiacomi G, Pugliese L, Ricci F, Floris R, Fusco A. High-resolution computed tomography and magnetic resonance imaging protocols in the diagnosis of fibrotic interstitial lung disease: overview for "non-radiologists". SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES 2017; 34:300-306. [PMID: 32476862 DOI: 10.36141/svdld.v34i4.5792] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 09/30/2016] [Accepted: 08/10/2017] [Indexed: 11/02/2022]
Abstract
Fibrotic interstitial lung diseases (ILDs) include a number of pulmonary disorders characterized by infiltration of inflammatory cells in lung parenchyma and fibrosis resulting in decreased lung compliance. Idiopathic pulmonary fibrosis (IPF) represents the most common ILD. ILDs can be divided in two anatomo-pathological and radiographic patterns: usual interstitial pneumonitis (UIP) and non-specific interstitial pneumonitis (NSIP). The different radiological features of UIP and NSIP are discussed. The American Thoracic Society, the European Respiratory Society, the Japanese Respiratory Society, and the Latin American Thoracic Association guidelines for the diagnosis and management of IPF have identified several characteristic high-resolution computed tomography (HRCT) features of UIP. However, even if these guidelines recommend to avoid surgical lung biopsy in case of confident UIP diagnosis on HRCT, they present some limitations, the most important of which is represented by interobserver agreement. Magnetic resonance imaging (MRI) can be considered as a radiation-free alternative to HRCT for several lung diseases. However, the clinical value of MRI for IPF diagnosis remains to be proven. (Sarcoidosis Vasc Diffuse Lung Dis 2017; 34: 300-306).
Collapse
Affiliation(s)
- Gianluigi Sergiacomi
- Department of Diagnostic Imaging, Molecular Imaging, Interventional Radiology and Radiotherapy, University of Rome "Tor Vergata", Rome, Italy
| | - Luca Pugliese
- Department of Diagnostic Imaging, Molecular Imaging, Interventional Radiology and Radiotherapy, University of Rome "Tor Vergata", Rome, Italy
| | - Francesca Ricci
- Department of Diagnostic Imaging, Molecular Imaging, Interventional Radiology and Radiotherapy, University of Rome "Tor Vergata", Rome, Italy
| | - Roberto Floris
- Department of Diagnostic Imaging, Molecular Imaging, Interventional Radiology and Radiotherapy, University of Rome "Tor Vergata", Rome, Italy
| | - Armando Fusco
- Department of Diagnostic Imaging, Molecular Imaging, Interventional Radiology and Radiotherapy, University of Rome "Tor Vergata", Rome, Italy
| |
Collapse
|
15
|
Computed tomography protocols used in staging bronchopulmonary carcinoma: Results of a national survey. RADIOLOGIA 2016. [DOI: 10.1016/j.rxeng.2016.11.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|
16
|
García Garrigós E, Arenas Jiménez JJ, Sánchez Payá J, Sirera Matilla M, Gayete Cara À. Computed tomography protocols used in staging bronchopulmonary carcinoma: results of a national survey. RADIOLOGIA 2016; 58:460-467. [PMID: 27457089 DOI: 10.1016/j.rx.2016.06.005] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2016] [Revised: 06/01/2016] [Accepted: 06/03/2016] [Indexed: 11/19/2022]
Abstract
OBJECTIVES To know the protocols used for staging bronchopulmonary carcinoma by computed tomography in Spain. MATERIAL AND METHODS Radiologists in 129 hospitals were sent email questionnaires about the organization of their department, scanner type and manufacturer, study extension, techniques employed, and protocol for administering contrast material. RESULTS A total of 109 hospitals responded with data from 91 teams. Most hospitals were affiliated with a university, and most departments were organized by organ-systems. Scanners were from four manufacturers, and 68% had either 16 or 64 detectors. In 61% of the hospitals, the dose of contrast agent is modified only in patients with extreme body weights, and in 22% the dose is not individualized. Most hospitals do contrast-enhanced studies of the chest and upper abdomen, 42.4% through a single thoracoabdominal acquisition and 55.9% through independent chest and abdominal acquisitions; there was a significant association between these approaches and the scanner manufacturer's protocols and whether the hospital was affiliated with a university. The most commonly used technical parameters were 120kV with dose modulation and variable milliamperage. CONCLUSION There is very little variability among hospitals in the type of scanner used, the study extension, and the technical parameters used to stage bronchopulmonary carcinoma. Most centers individualize the dose of contrast agent only in extreme weights. There is a broad division between using one or two acquisitions to image the thorax and abdomen, and the number of acquisitions is related to the scanner manufacturer and whether the hospital is affiliated with a university.
Collapse
Affiliation(s)
- E García Garrigós
- Servicio de Radiodiagnóstico, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL) - Fundación FISABIO, Alicante, España
| | - J J Arenas Jiménez
- Servicio de Radiodiagnóstico, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL) - Fundación FISABIO, Alicante, España.
| | - J Sánchez Payá
- Servicio de Medicina Preventiva, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL) - Fundación FISABIO, Alicante, España
| | - M Sirera Matilla
- Servicio de Radiodiagnóstico, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL) - Fundación FISABIO, Alicante, España
| | - À Gayete Cara
- Servicio de Radiodiagnóstico, Hospital del Mar, Barcelona, España
| |
Collapse
|
17
|
Schaefer-Prokop C, Prosch H. Interstitial lung diseases. IMAGING 2016. [DOI: 10.1183/2312508x.10003015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
|
18
|
Abstract
Until today, computed tomography (CT) is the most important and valuable radiological modality to detect, analyze, and diagnose diffuse interstitial lung diseases (DILD), based on the unsurpassed morphological detail provided by high-resolution CT technique. In the past decade, there has been a shift from an isolated histopathological diagnosis to a multidisciplinary acquired diagnosis consensus that is nowadays regarded to provide the highest level of diagnostic accuracy in patients with diffuse interstitial lung diseases. The 2002 ATS/ERS statement on classification of idiopathic interstitial pneumonias assigned a central role to high-resolution CT (HRCT) in the diagnostic workup of idiopathic interstitial pneumonias (ATS/ERS consensus classification 2002). The more recent 2013 ERS/ATS statement reinforced that combined clinical data (presentation, exposures, smoking status, associated diseases, lung function, and laboratory findings) and radiological findings are essential for a multidisciplinary diagnosis (Travis et al., Am J Respir Crit Care Med 188(6):733–748, 2013). The traditional HRCT consisted of discontinuous 1 mm high-resolution axial slices. The primary focus was on visual pattern analysis demanding for the highest possible spatial resolution. Because of the intrinsic high structural contrast of the lung, it has been possible to substantially reduce dose without losing diagnostic information. This development has been supported by new detection and reconstruction techniques. Not only detection of subtle disease and visual comparison of disease stage but also disease classification and quantification nowadays take advantage of continuous volumetric data acquisition provided by multidetector row (MD) CT technique. The following book chapter will focus on acquisition technique with special emphasis on dose and reconstruction, advantages, and new diagnostic options of volumetric MDCT technique for interstitial lung diseases. Based on evidence from the literature, certain diseases will be covered more specifically, but it has to be noted that for the pattern analysis of the various interstitial lung diseases, the plethora of other publications and books is recommended.
Collapse
Affiliation(s)
- U. Joseph Schoepf
- Department of Radiology and Radiological Science, Medical University of South Carolina, Charleston, South Carolina USA
| | - Felix G. Meinel
- Institute for Clinical Radiology, Ludwig-Maximilians-University Hospital, Munich, Germany
| |
Collapse
|
19
|
Wallace B, Kafaja S, Furst DE, Berrocal VJ, Merkel PA, Seibold JR, Mayes MD, Khanna D. Reliability, validity and responsiveness to change of the Saint George's Respiratory Questionnaire in early diffuse cutaneous systemic sclerosis. Rheumatology (Oxford) 2015; 54:1369-79. [PMID: 25667436 PMCID: PMC4502336 DOI: 10.1093/rheumatology/keu456] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2014] [Indexed: 01/17/2023] Open
Abstract
OBJECTIVE Dyspnoea is a common, multifactorial source of functional impairment among patients with dcSSc. Our objective was to assess the reliability, construct validity and responsiveness to change of the Saint George's Respiratory Questionnaire (SGRQ) in patients with early dcSSc participating in a multicentre prospective study. METHODS At enrolment and 1 year, patients completed the SGRQ (a multi-item instrument with four scales: symptoms, activity, impact and total), a visual analogue scale (VAS) for breathing and the HAQ Disability Index (HAQ-DI) and underwent 6 min walk distance and pulmonary function tests, physician and patient global health assessments and high-resolution CT (HRCT). We assessed internal consistency reliability using Cronbach's α. For validity we examined the ability of the SGRQ to differentiate the presence vs absence of interstitial lung disease (ILD) on HRCT or restrictive lung disease and evaluated the 1 year responsiveness to change using pulmonary function tests and patient- and physician-reported anchors. Correlation coefficients of 0.24-0.36 were considered moderate and >0.37 was considered large. RESULTS A total of 177 patients were evaluated. Reliability was satisfactory for all SGRQ scales (0.70-0.93). All scales showed large correlations with the VAS for breathing and diffusing capacity of the lung for carbon monoxide in the overall cohort and in the subgroup with ILD. Three of the four scales in the overall cohort and the total scale in the ILD subgroup showed moderate to large correlation with the HAQ-DI and the predicted forced vital capacity (r = 0.33-0.44). Each scale discriminated between the presence and absence of ILD and restrictive lung disease (P ≤ 0.0001-0.03). At follow-up, all scales were responsive to change using different anchors. CONCLUSION The SGRQ has acceptable reliability, construct validity and responsiveness to change for use in a dcSSc population and differentiates between patients with and without ILD.
Collapse
Affiliation(s)
- Beth Wallace
- Division of Rheumatology, University of Michigan, Ann Arbor, MI
| | | | | | - Veronica J. Berrocal
- Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, MI
| | - Peter A. Merkel
- Department of Internal Medicine, University of Pennsylvania, Philadelphia, PA
| | | | - Maureen D. Mayes
- Division of Rheumatology, University of Texas Health Science Center, Houston, TX and
| | - Dinesh Khanna
- Division of Rheumatology, Department of Internal Medicine, University of Michigan Scleroderma Program, Ann Arbor, MI, USA
| |
Collapse
|
20
|
T2 mapping of CT remodelling patterns in interstitial lung disease. Eur Radiol 2015; 25:3167-74. [PMID: 26037715 DOI: 10.1007/s00330-015-3751-y] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/20/2014] [Revised: 02/15/2015] [Accepted: 03/30/2015] [Indexed: 10/23/2022]
Abstract
OBJECTIVES To evaluate lung T2 mapping for quantitative characterization and differentiation of ground-glass opacity (GGO), reticulation (RE) and honeycombing (HC) in usual interstitial pneumonia (UIP) and non-specific interstitial pneumonia (NSIP). METHODS Twelve patients with stable UIP or NSIP underwent thin-section multislice CT and 1.5-T MRI of the lung. A total of 188 regions were classified at CT into normal (n = 29) and pathological areas, including GGO (n = 48), RE (n = 60) and HC (n = 51) predominant lesions. Entire lung T2 maps based on multi-echo single shot TSE sequence (TE: 20, 40, 79, 140, 179 ms) were generated from each subject with breath-holds at end-expiration and ECG-triggering. RESULTS The median T2 relaxation of GGO was 67 ms (range 60-72 ms). RE predominant lesions had a median relaxation of 74 ms (range 69-79 ms), while for HC pattern this was 79 ms (range 74-89 ms). The median T2 relaxation for normal lung areas was 41 ms (ranged 38-49 ms), and showed significant difference to pathological areas (p < 0.001). A statistical difference was found between the T2 relaxation of GGO, RE and HC (p < 0.05). CONCLUSIONS The proposed method provides quantitative information for pattern differentiation, potentially allowing for monitoring of progression and response to treatment, in interstitial lung disease. KEY POINTS • Multi-echo single shot TSE sequence allows for entire lung T2 mapping. • Lung remodelling patterns in ILD show different T2 relaxation. • Quantitative T2 mapping may provide information for monitoring of ILD.
Collapse
|
21
|
Rutty GN, Biggs MJP, Brough A, Robinson C, Mistry R, Amoroso J, Deshpande A, Morgan B. Ventilated post-mortem computed tomography through the use of a definitive airway. Int J Legal Med 2014; 129:325-34. [PMID: 25524761 DOI: 10.1007/s00414-014-1135-5] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2014] [Accepted: 12/08/2014] [Indexed: 11/30/2022]
Abstract
Ventilated post-mortem computed tomography (VPMCT) has been shown to achieve lung expansion in cadavers and has been proposed to enhance the diagnosis of lung pathology. Two key problems of the method of ventilation have been identified: firstly, the presence of head and neck rigor making airway insertion challenging and, secondly, air leak, if there is not a good seal around the airway, which diminishes lung expansion and causes inflation of the stomach. Simple procedures to insert a 'definitive' cuffed airway, which has a balloon inflated within the trachea, are therefore desirable. This study aims to test different procedures for inserting cuffed airways in cadavers and compare their ventilation efficacy and to propose a decision algorithm to select the most appropriate method. We prospectively tested variations on two ways of inserting a cuffed airway into the trachea: firstly, using an endotracheal tube (ET) approach, either blind or by direct visualisation, and, secondly, using a tracheostomy incision, either using a standard tracheostomy tube or shortened ET tube. We compare these approaches with a retrospective analysis of a previously reported series using supraglottic airways. All techniques, except 'blind' insertion of ET tubes, were possible with adequate placement of the airway in most cases. However, achieving both adequate insertion and a complete tracheal seal was better for definitive airways with 56 successful cases from 59 (95 %), compared with 9 cases from 18 (50 %) using supraglottic airways (p < 0.0001). Good lung expansion was achieved using all techniques if the airway was adequately positioned and achieved a good seal, and there was no significant chest pathology. We prefer inserting a shortened ET tube via a tracheostomy incision, as we find this the easiest technique to perform and train. Based on our experience, we have developed a decision algorithm to select the most appropriate method for VPMCT.
Collapse
Affiliation(s)
- Guy N Rutty
- East Midlands Forensic Pathology Unit, University of Leicester, Robert Kilpatrick Building, Leicester, LE2 7LX, UK,
| | | | | | | | | | | | | | | |
Collapse
|
22
|
Morgan B, Adlam D, Robinson C, Pakkal M, Rutty GN. Adult post-mortem imaging in traumatic and cardiorespiratory death and its relation to clinical radiological imaging. Br J Radiol 2014; 87:20130662. [PMID: 24338941 DOI: 10.1259/bjr.20130662] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022] Open
Abstract
The use of post-mortem imaging is expanding throughout the world with increasing use of advanced imaging techniques, such as contrast-enhanced CT and MRI. The questions asked of post-mortem imaging are complex and can be very different, for example for natural sudden death investigation will focus on the cause, whereas for trauma the cause of death is often clear, but injury patterns may be very revealing in investigating the background to the incident. Post-mortem imaging is different to clinical imaging regarding both the appearance of pathology and the information required, but there is much to learn from many years of clinical research in the use of these techniques. Furthermore, it is possible that post-mortem imaging research could be used not only for investigating the cause of death but also as a model to conduct clinically relevant research. This article reviews challenges to the development of post-mortem imaging for trauma, identification and cardiorespiratory death, and how they may be influenced by current clinical thinking and practice.
Collapse
Affiliation(s)
- B Morgan
- Imaging Department, University Hospitals of Leicester, Leicester Royal Infirmary, Leicester, UK
| | | | | | | | | |
Collapse
|
23
|
Conversion factors for determining organ doses received by paediatric patients in high-resolution single slice computed tomography with narrow collimation. Z Med Phys 2014; 24:123-37. [PMID: 24630933 DOI: 10.1016/j.zemedi.2014.02.001] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2013] [Revised: 02/05/2014] [Accepted: 02/06/2014] [Indexed: 01/24/2023]
Abstract
Estimations of organ doses DT received during computed tomographic examinations are usually performed by applying conversion factors to basic dose indicators like the computed tomography dose index (CTDI) or the dose-length-product (DLP). In addition to the existing conversion factors for beam apertures of 5 mm or 10 mm, we present new DLP-DT conversion factors adapted to high-resolution CT (HRCT) examinations of infants and young children with beam apertures of the order of 1 mm and under consideration of bow tie filtration. Calculations are performed on mathematical MIRD phantoms for an age range from 0, 1, 5, 10, 15 up to (for comparison) 30 years by adapting PCXMC, a Monte Carlo algorithm originally developed by STUK (Helsinki, Finland) for dose reconstructions in projection radiography. For this purpose, each single slice CT examination is approximated by a series of corresponding virtual planar radiographies comprising all focus positions. The transformation of CT exposure parameters into exposure parameters of the series of corresponding planar radiographies is performed by a specially developed algorithm called XCT. The DLP values are evaluated using the EGSRay code. The new method is verified at a beam aperture of 10 mm by comparison with formerly published conversion factors. We show that the higher spatial resolution leads to an enhanced DLP-DT conversion factor if a small organ (e. g. thyroid gland, mammae, uterus, ovaries, testes) is exactly met by the chosen CT slice, while the conversion factor is drastically reduced if the chosen CT slice is positioned above or below the organ. This effect is utilized for dose-saving examinations with only a few single slices instead a full scan, which technique is applied in about 10% of all paediatric chest CT examinations.
Collapse
|
24
|
Robinson C, Biggs MJ, Amoroso J, Pakkal M, Morgan B, Rutty GN. Post-mortem computed tomography ventilation; simulating breath holding. Int J Legal Med 2013; 128:139-46. [PMID: 24276489 DOI: 10.1007/s00414-013-0943-3] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2013] [Accepted: 11/08/2013] [Indexed: 11/29/2022]
Abstract
Whilst the literature continues to report on advances in the use of post-mortem computed tomography (PMCT), particularly in relation to post-mortem angiography, there are few papers published that address the diagnostic problems related to post-mortem changes in the lungs and ventilation. We present a development of previous methods to achieve ventilated PMCT (VPMCT). We successfully introduced a supraglottic airway in 17/18 cases without causing overt damage, despite rigor mortis. Using a clinical portable ventilator, we delivered continuous positive airway pressure to mimic clinical breath-hold inspiratory scans. This caused significant lung expansion and a reduction in lung density and visible normal post-mortem changes. All thoracic pathology identified at autopsy, including pneumonia, was diagnosed on VPMCT in this small series. This technique provides a rapid form of VPMCT, which can be used in both permanent and temporary mortuaries, allowing for the post-mortem radiological comparison of pre-ventilation and post-ventilation images mimicking expiratory and inspiratory phases. We believe that it will enhance the diagnostic ability of PMCT in relation to lung pathology.
Collapse
Affiliation(s)
- C Robinson
- Imaging Department, University Hospitals of Leicester, Leicester Royal Infirmary, Leicester, LE2 7LX, UK
| | | | | | | | | | | |
Collapse
|